Bulgaria's Puldin Holding acquires TIZ Invest
Albania sells 29.5 mln euro of 2028 T-notes
Bulgaria's 614 mln euro push-pull trains tender gets two bids
Albania to offer 15 mln euro of 2030 T-notes
Bulgaria's Express Service wins 5.4 mln euro electric shunters tender
Dec 14, 2017 14:20 EEST
SOFIA (Bulgaria), December 14 (SeeNews) – Bulgarian drug maker Sopharma [BUL:3JR] said on Thursday it has acquired 6,251 of its own shares at an average weighted price of 4.28 levs ($2.6/2.2 euro) apiece as part of its share repurchase programme.
The shares, representing a stake of 0.0046% in the company, were bought back on December 13, Sopharma said in a statement.
Currently, Sopharma holds 8.89 million of its own shares, equal to a 6.59% stake in the company.
Sopharma plans to repurchase 10% of its own shares under a buyback programme approved in June 2010.
(1 euro = 1.95583 levs)
You have run out of free articles this month.
Sign up in for
and get ten (10) free articles per month or sign up for
and get unlimited access.
Browse our free newsletter options